Yatsunami J - Search Results

1

Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.

Bai F, Nakanishi Y, Kawasaki M, Takayama K, Yatsunami J, Pei XH, Tsuruta N, Wakamatsu K, Hara N. Bai F, et al. Among authors: yatsunami j. Cancer. 1996 Aug 1;78(3):416-21. doi: 10.1002/(SICI)1097-0142(19960801)78:3<416::AID-CNCR6>3.0.CO;2-H. Cancer. 1996. PMID: 8697385

2

Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.

Takayama K, Ogata K, Nakanishi Y, Yatsunami J, Kawasaki M, Hara N. Takayama K, et al. Among authors: yatsunami j. Cancer J Sci Am. 1996 Jul-Aug;2(4):212-6. Cancer J Sci Am. 1996. PMID: 9166534

3

P53 immunostaining predicts chemosensitivity in non-small cell lung cancer: A preliminary report.

Kawasaki M, Nakanishi Y, Yatsunami J, Takayama K, Ochiai S, Xinhai P, Kuwano K, Hara N. Kawasaki M, et al. Among authors: yatsunami j. Cancer J Sci Am. 1996 Jul-Aug;2(4):217-20. Cancer J Sci Am. 1996. PMID: 9166535

4

Glutathione derivatives enhance adriamycin cytotoxicity in a human lung adenocarcinoma cell line.

Nakanishi Y, Matsuki H, Takayama K, Yatsunami J, Kawasaki M, Abe M, Hara N. Nakanishi Y, et al. Among authors: yatsunami j. Anticancer Res. 1997 May-Jun;17(3C):2129-34. Anticancer Res. 1997. PMID: 9216676

5

Phase II trial of dose intensification with cisplatin and carboplatin plus vindesine in patients with inoperable non-small cell lung cancer.

Nakanishi Y, Takayama K, Kawasaki M, Yatsunami J, Inutsuka S, Wakamatsu K, Tsuruta N, Hara N. Nakanishi Y, et al. Among authors: yatsunami j. Am J Clin Oncol. 1997 Aug;20(4):393-7. doi: 10.1097/00000421-199708000-00015. Am J Clin Oncol. 1997. PMID: 9256897 Clinical Trial.

6

[Expression of CD44 standard and CD44 variant 6 in human lung cancer].

Ochiai S, Nakanishi Y, Mizuno K, Hashimoto S, Inutsuka S, Kawasaki M, Yatsunami J, Hara N. Ochiai S, et al. Among authors: yatsunami j. Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Nov;35(11):1179-85. Nihon Kyobu Shikkan Gakkai Zasshi. 1997. PMID: 9493443 Japanese.

7

Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung.

Yatsunami J, Tsuruta N, Ogata K, Wakamatsu K, Takayama K, Kawasaki M, Nakanishi Y, Hara N, Hayashi S. Yatsunami J, et al. Cancer Lett. 1997 Nov 25;120(1):101-8. doi: 10.1016/s0304-3835(97)00296-6. Cancer Lett. 1997. PMID: 9570392

8

Granulocyte-macrophage-colony stimulating factor stimulates tumor invasiveness in squamous cell lung carcinoma.

Tsuruta N, Yatsunami J, Takayama K, Nakanishi Y, Ichinose Y, Hara N. Tsuruta N, et al. Among authors: yatsunami j. Cancer. 1998 Jun 1;82(11):2173-83. Cancer. 1998. PMID: 9610697

9

The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.

Kawasaki M, Nakanishi Y, Kuwano K, Yatsunami J, Takayama K, Hara N. Kawasaki M, et al. Among authors: yatsunami j. Clin Cancer Res. 1997 Jul;3(7):1195-200. Clin Cancer Res. 1997. PMID: 9815799

10

Inhibition of tumor angiogenesis by roxithromycin, a 14-membered ring macrolide antibiotic.

Yatsunami J, Tsuruta N, Hara N, Hayashi S. Yatsunami J, et al. Cancer Lett. 1998 Sep 25;131(2):137-43. doi: 10.1016/s0304-3835(98)00110-4. Cancer Lett. 1998. PMID: 9851245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters